Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [41] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Taher M. Mandviwala
    Sukhdeep S. Basra
    Umair Khalid
    June K. Pickett
    Ryle Przybylowicz
    Tina Shah
    Vijay Nambi
    Salim S. Virani
    Anita Deswal
    International Journal of Obesity, 2020, 44 : 1561 - 1567
  • [42] Prognosis of Heart Failure with Stable Mid-Range Ejection Fraction in Comparison to Heart Failure with Stable Reduced Ejection Fraction and Heart Failure with Stable Preserved Ejection Fraction
    Soufi, Mohamad Khaled
    Almahmoud, Mohamed Faher
    Jain, Rishabh R.
    Mcfarland, Joseph R.
    Pinsky, Simon
    Rana, Milin N.
    Ogbonna, Precious
    Khalife, Wissam I.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S152 - S152
  • [43] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Mandviwala, Taher M.
    Basra, Sukhdeep S.
    Khalid, Umair
    Pickett, June K.
    Przybylowicz, Ryle
    Shah, Tina
    Nambi, Vijay
    Virani, Salim S.
    Deswal, Anita
    INTERNATIONAL JOURNAL OF OBESITY, 2020, 44 (07) : 1561 - 1567
  • [44] Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
    Antonelli, Lucas
    Katz, Marcelo
    Bacal, Fernando
    Pinho Makdisse, Marcia Regina
    Correa, Alessandra Graca
    Pereira, Carolina
    Franken, Marcelo
    Fava, Anderson Nunes
    Serrano Junior, Carlos Vicente
    Pereira Pesaro, Antonio Eduardo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 105 (02) : 145 - 149
  • [45] Skin Autofluorescence as a Predictor of First Heart Failure Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction
    Hitsumoto, Takashi
    CARDIOLOGY RESEARCH, 2020, 11 (04) : 247 - 255
  • [46] Predictors of Heart Failure Related Death or Hospitalization in Patients with Heart Failure due to Preserved Ejection Fraction
    Calvin, James E.
    Mangla, Ashvarya
    Beaty, Elijah
    Kane, John
    Richardson, Dejuran
    Powell, Lynda H.
    CIRCULATION, 2012, 126 (21)
  • [47] ECHOCARDIOGRAPHIC ASSESSMENT OF PULMONARY HYPERTENSION: A COMPARISON BETWEEN HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION
    Wada, Hiroshi
    Sakakura, Kenichi
    Ako, Junya
    Momomura, Shin-ichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E893 - E893
  • [48] Risk factors for heart failure rehospitalization in patients with preserved ejection fraction : Comparison between preserved ejection fraction and reduced ejection fraction
    Setoguchi, M.
    Hashimoto, Y.
    Isobe, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S282 - S282
  • [49] Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT
    Szabo, Barna
    Benson, Lina
    Savarese, Gianluigi
    Hage, Camilla
    Fudim, Marat
    Devore, Adam
    Pitt, Bertram
    Lund, Lars H.
    AMERICAN HEART JOURNAL, 2024, 271 : 136 - 147
  • [50] Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction
    Bello, Natalie A.
    Claggett, Brian
    Desai, Akshay S.
    McMurray, John J. V.
    Granger, Christopher B.
    Yusuf, Salim
    Swedberg, Karl
    Pfeffer, Marc A.
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2014, 7 (04) : 590 - 595